Houston clinic launches study to catch liver cancer early
NCT ID NCT04785534
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study aims to find early signs of liver damage that can lead to liver cancer. Researchers will use surveys, blood tests, and a special liver scan (fibroscan) to screen 1,000 patients at the HOPE clinic. The goal is to learn how to better prevent or detect liver cancer early, which may improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER AND INTRAHEPATIC BILE DUCT CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.